Literature DB >> 22890483

Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation.

Pietro Turco1, Antonio D'Onofrio, Giuseppe Stabile, Francesco Solimene, Vincenzo La Rocca, Filippo Vecchione, Assunta Iuliano, Natale Marrazzo, Stefano De Vivo, Ciro Cavallaro, Valter Bianchi, Alessia Agresta, Carmine Ciardiello, Antonio De Simone.   

Abstract

PURPOSE: Patients with permanent atrial fibrillation (AF) who undergo cardiac resynchronization therapy (CRT) may spontaneously recover sinus rhythm during follow-up. We tested the feasibility and efficacy of electrical cardioversion attempted after 3 months of CRT in patients with permanent AF and measured the long-term maintenance of sinus rhythm.
METHODS: Twenty-eight consecutive patients with permanent AF in whom CRT defibrillators had been implanted were scheduled for internal electrical cardioversion after 3 months (group A) and were compared with a control group of 27 patients (group B).
RESULTS: In group A, 22 patients (79 %) were eligible for cardioversion; sinus rhythm was restored in 18 (82 %) of these, with no procedural complications. After 12 months, 16 patients (58 %) in group A were in sinus rhythm, compared with one group B patient who spontaneously recovered sinus rhythm (4 %, p < 0.001). On 12-month evaluation, ejection fraction had improved in both groups, but a reduction in left ventricular end-systolic volume was recorded only in group A patients (p = 0.018 versus baseline).
CONCLUSIONS: In patients with permanent AF, the rhythm control strategy consisting of internal cardioversion, performed by means of the implanted cardioverter-defibrillator after 3 months of CRT, was associated with a high rate of sinus rhythm resumption on long-term follow-up and with a better echocardiographic response to CRT than that seen in patients treated according to a rate control strategy.

Entities:  

Mesh:

Year:  2012        PMID: 22890483     DOI: 10.1007/s10840-012-9713-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  17 in total

1.  Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study.

Authors:  S Cazeau; P Bordachar; G Jauvert; A Lazarus; C Alonso; M C Vandrell; J Mugica; P Ritter
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

2.  Cardiac resynchronization therapy in patients with atrial fibrillation: is atrial lead implantation necessary?

Authors:  Carsten W Israel; S Serge Barold
Journal:  Pacing Clin Electrophysiol       Date:  2008-03       Impact factor: 1.976

3.  Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation.

Authors:  H C Dittrich; J S Erickson; T Schneiderman; A R Blacky; T Savides; P H Nicod
Journal:  Am J Cardiol       Date:  1989-01-15       Impact factor: 2.778

Review 4.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

5.  Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function.

Authors:  H F Tse; C P Lau
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

6.  Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics.

Authors:  Burkhard Hügl; Hans-Jürgen Bruns; Christine Unterberg-Buchwald; Anett Grosse; Berthold Stegemann; Bernward Lauer; J Christoph Geller; Maurizio Gasparini
Journal:  J Cardiovasc Electrophysiol       Date:  2006-08

7.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; François Regoli; Cecilia Fantoni; Mihoko Kawabata; Paola Galimberti; Daniela Pini; Carlo Ceriotti; Edoardo Gronda; Catherine Klersy; Simona Fratini; Helmut H Klein
Journal:  J Am Coll Cardiol       Date:  2006-07-24       Impact factor: 24.094

8.  Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.

Authors:  Maurizio Gasparini; Jonathan S Steinberg; Aysha Arshad; François Regoli; Paola Galimberti; Arnaud Rosier; Jean Claude Daubert; Catherine Klersy; Ganesh Kamath; Christophe Leclercq
Journal:  Eur Heart J       Date:  2010-01-12       Impact factor: 29.983

9.  Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction.

Authors:  Giuseppe Boriani; Mauro Biffi; Claudia Camanini; Ivan Corazza; Cristian Martignani; Cinzia Valzania; Margherita Gallina; Francesco Grigioni; Romano Zannoli; Claudio Rapezzi; Angelo Branzi
Journal:  Int J Cardiol       Date:  2004-05       Impact factor: 4.164

10.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; Marco Metra; François Regoli; Cecilia Fantoni; Barbara Lamp; Antonio Curnis; Juergen Vogt; Catherine Klersy
Journal:  Eur Heart J       Date:  2008-04-04       Impact factor: 29.983

View more
  8 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 2.  Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.

Authors:  J Lüker; A Sultan; T Plenge; J van den Bruck; C-H Heeger; S Meyer; K Mischke; R R Tilz; D Vollmann; G Nölker; B Schäffer; S Willems; D Steven
Journal:  Clin Res Cardiol       Date:  2017-11-18       Impact factor: 5.460

Review 3.  Cardiac Resynchronization in Patients with Atrial Fibrillation.

Authors:  S Serge Barold; Bengt Herweg
Journal:  J Atr Fibrillation       Date:  2015-12-31

4.  Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze.

Authors:  W R Berger; R E Knops; J R de Groot
Journal:  Neth Heart J       Date:  2013-12       Impact factor: 2.380

5.  Atrial fibrillation in cardiac resynchronization therapy.

Authors:  Mark K Elliott; Vishal S Mehta; Dejana Martic; Baldeep S Sidhu; Steven Niederer; Christopher A Rinaldi
Journal:  Heart Rhythm O2       Date:  2021-12-17

6.  Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation.

Authors:  Antonio Rapacciuolo; Saverio Iacopino; Antonio D'Onofrio; Antonio Curnis; Ennio C Pisanò; Mauro Biffi; Paolo Della Bella; Antonio Dello Russo; Fabrizio Caravati; Gabriele Zanotto; Valeria Calvi; Giovanni Rovaris; Gaetano Senatore; Daniele Nicolis; Matteo Santamaria; Massimo Giammaria; Giampiero Maglia; Antonio Duca; Giuseppe Ammirati; Salvo Andrea Romano; Marcello Piacenti; Eduardo Celentano; Giovanni Bisignani; Paola Vaccaro; Gennaro Miracapillo; Matteo Bertini; Gerardo Nigro; Daniele Giacopelli; Alessio Gargaro; Caterina Bisceglia
Journal:  ESC Heart Fail       Date:  2021-09-12

7.  Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator.

Authors:  I Limantoro; K Vernooy; B Weijs; R Pisters; L Debie; H J Crijns; Y Blaauw
Journal:  Neth Heart J       Date:  2013-12       Impact factor: 2.380

8.  Comparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of Cardiac Resynchronization in Atrial Fibrillation Trial (Pilot-CRAfT): study protocol for a randomized controlled trial.

Authors:  Jan Ciszewski; Aleksander Maciag; Ilona Kowalik; Pawel Syska; Michal Lewandowski; Michal M Farkowski; Anna Borowiec; Tomasz Chwyczko; Mariusz Pytkowski; Hanna Szwed; Maciej Sterlinski
Journal:  Trials       Date:  2014-10-04       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.